Acute effect of acetazolamide on exercise haemodynamics in patients with pulmonary arterial and chronic thromboembolic pulmonary hypertension: a randomised controlled trial
Intravenous acetazolamide was well tolerated and resulted in a significant but small decrease in mPAP, while CO, PVR and the pressure-flow slope during exercise were unchanged.
Authors
- Silvia Ulrich (ORCID: https://orcid.org/0000-0002-5250-5022)
- Mona Lichtblau (ORCID: https://orcid.org/0000-0003-4485-1758)
- Esther Irene Schwarz (ORCID: https://orcid.org/0000-0001-8840-981X)
- Stéphanie Saxer (ORCID: https://orcid.org/0000-0002-3278-6277)
- Arcangelo F. Carta (ORCID: https://orcid.org/0000-0001-8019-7429)
- Laura C. Mayer (ORCID: https://orcid.org/0009-0004-4949-8548)
- Erik R. Swenson
- Michaël Furian (ORCID: https://orcid.org/0000-0002-8518-5029)
- Simon Schneider (ORCID: https://orcid.org/0000-0003-3635-0515)
- Konrad E. Bloch (ORCID: https://orcid.org/0000-0002-2377-7387)
Institutions
- University of Washington (US)
- VA Puget Sound Health Care System (US)
- University Hospital of Zurich (CH)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1183/23120541.00782-2024
- Citations
- 1
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung